Literature DB >> 23022352

Influenza virus neuraminidase contributes to the dextran sulfate-dependent suppressive replication of some influenza A virus strains.

Hiroshi Yamada1, Eiko Moriishi, Ahmad M Haredy, Nobuyuki Takenaka, Yasuko Mori, Koichi Yamanishi, Shigefumi Okamoto.   

Abstract

Dextran sulfate (DS), a negatively charged, sulfated polysaccharide, suppresses the replication of an influenza A virus strain, and this suppression is associated with inhibition of the hemagglutinin (HA)-dependent fusion activity. However, it remains unknown whether the replication of all or just some influenza A virus strains is suppressed by DS, or whether HA is the only target for the replication suppression. In the present study, we found that DS inhibited the replication of some, but not all influenza A virus strains. The suppression in the DS-sensitive strains was dose-dependent and neutralized by diethylaminoethyl-dextran (DD), which has a positive charge. The suppression by DS was observed not only at the initial stage of viral infection, which includes viral attachment and entry, but also at the late stage, which includes virus assembly and release from infected cells. Electron microscopy revealed that the DS induced viral aggregation at the cell surface. The neuraminidase (NA) activity of the strains whose viral replication was inhibited at the late stage was also more suppressed by DS than that of the strains whose replication was not inhibited, and this inhibition of NA activity was also neutralized by adding positively charged DD. Furthermore, we found that replacing the NA gene of a strain in which viral replication was inhibited by DS at the late stage with the NA gene from a strain in which viral replication was not inhibited, eliminated the DS-dependent suppression. These results suggest that the influenza virus NA contributes to the DS-suppressible virus release from infected cells at the late stage, and the suppression may involve the inhibition of NA activity by DS's negative charge.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23022352     DOI: 10.1016/j.antiviral.2012.09.012

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  7 in total

1.  Novel Polyanions Inhibiting Replication of Influenza Viruses.

Authors:  Justyna Ciejka; Aleksandra Milewska; Magdalena Wytrwal; Jacek Wojarski; Anna Golda; Marek Ochman; Maria Nowakowska; Krzysztof Szczubialka; Krzysztof Pyrc
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

2.  An MDCK cell culture-derived formalin-inactivated influenza virus whole-virion vaccine from an influenza virus library confers cross-protective immunity by intranasal administration in mice.

Authors:  Ahmad M Haredy; Nobuyuki Takenaka; Hiroshi Yamada; Yoshihiro Sakoda; Masatoshi Okamatsu; Naoki Yamamoto; Takeshi Omasa; Hisao Ohtake; Yasuko Mori; Hiroshi Kida; Koichi Yamanishi; Shigefumi Okamoto
Journal:  Clin Vaccine Immunol       Date:  2013-05-01

Review 3.  Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus.

Authors:  R Gasparini; D Amicizia; P L Lai; N L Bragazzi; D Panatto
Journal:  J Prev Med Hyg       Date:  2014-12

4.  Non-human primate orthologues of TMPRSS2 cleave and activate the influenza virus hemagglutinin.

Authors:  Pawel Zmora; Paulina Molau-Blazejewska; Stephanie Bertram; Kerstin Walendy-Gnirß; Inga Nehlmeier; Anika Hartleib; Anna-Sophie Moldenhauer; Sebastian Konzok; Susann Dehmel; Katherina Sewald; Constantin Brinkmann; Christoph Curths; Sascha Knauf; Jens Gruber; Kerstin Mätz-Rensing; Franziska Dahlmann; Armin Braun; Stefan Pöhlmann
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

Review 5.  Progress of small molecular inhibitors in the development of anti-influenza virus agents.

Authors:  Xiaoai Wu; Xiuli Wu; Qizheng Sun; Chunhui Zhang; Shengyong Yang; Lin Li; Zhiyun Jia
Journal:  Theranostics       Date:  2017-02-08       Impact factor: 11.556

6.  A comparison of RSV and influenza in vitro kinetic parameters reveals differences in infecting time.

Authors:  Gilberto Gonzàlez-Parra; Filip De Ridder; Dymphy Huntjens; Dirk Roymans; Gabriela Ispas; Hana M Dobrovolny
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

7.  Toll-like receptor 9 ligand D-type oligodeoxynucleotide D35 as a broad inhibitor for influenza A virus replication that is associated with suppression of neuraminidase activity.

Authors:  Hiroshi Yamada; Satoshi Nagase; Kazuo Takahashi; Yoshihiro Sakoda; Hiroshi Kida; Shigefumi Okamoto
Journal:  Antiviral Res       Date:  2016-02-26       Impact factor: 5.970

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.